Reuters logo
BRIEF-Medtronic announces expanded FDA approval of self-expanding Corevalve Evolut TAVR platform​
July 10, 2017 / 3:42 PM / 2 months ago

BRIEF-Medtronic announces expanded FDA approval of self-expanding Corevalve Evolut TAVR platform​

July 10 (Reuters) - Medtronic Plc :

* Medtronic expands TAVR access to more patients with symptomatic, severe aortic stenosis upon intermediate risk FDA approval

* Medtronic Plc- ‍expanded U.S. FDA approval of self-expanding Corevalve Evolut Transcatheter Aortic Valve Replacement platform​

* Medtronic - ‍Expanded FDA approval to include patients with symptomatic severe aortic stenosis who are at an intermediate risk for open-heart surgery​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below